Renaissance Technologies’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,700
Closed -$93.9K 3668
2024
Q2
$93.9K Sell
14,700
-52,200
-78% -$334K ﹤0.01% 3195
2024
Q1
$504K Sell
66,900
-32,369
-33% -$244K ﹤0.01% 2862
2023
Q4
$919K Sell
99,269
-60,200
-38% -$557K ﹤0.01% 2462
2023
Q3
$1.61M Buy
159,469
+4,869
+3% +$49.3K ﹤0.01% 1989
2023
Q2
$1.93M Sell
154,600
-112,469
-42% -$1.41M ﹤0.01% 2016
2023
Q1
$3.12M Buy
267,069
+78,707
+42% +$919K ﹤0.01% 1754
2022
Q4
$2M Buy
188,362
+31,489
+20% +$335K ﹤0.01% 2065
2022
Q3
$1.52M Buy
156,873
+98,473
+169% +$955K ﹤0.01% 2226
2022
Q2
$846K Sell
58,400
-278,669
-83% -$4.04M ﹤0.01% 2819
2022
Q1
$8.81M Buy
337,069
+57,700
+21% +$1.51M 0.01% 1204
2021
Q4
$11.1M Buy
279,369
+79,300
+40% +$3.14M 0.01% 1018
2021
Q3
$10M Buy
200,069
+52,000
+35% +$2.6M 0.01% 1037
2021
Q2
$8.22M Sell
148,069
-9,408
-6% -$522K 0.01% 1318
2021
Q1
$7.37M Buy
+157,477
New +$7.37M 0.01% 1395